Polypharmacology: drug discovery for the future
In recent years, even with remarkable scientific advancements and a significant increase of global research and development spending, drugs are frequently withdrawn from markets. This is primarily due to their side effects or toxicities. Drug molecules often interact with multiple targets, coined as...
Saved in:
Published in | Expert review of clinical pharmacology Vol. 6; no. 1; pp. 41 - 47 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.01.2013
Taylor & Francis Expert Reviews Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In recent years, even with remarkable scientific advancements and a significant increase of global research and development spending, drugs are frequently withdrawn from markets. This is primarily due to their side effects or toxicities. Drug molecules often interact with multiple targets, coined as polypharmacology, and the unintended drug-target interactions could cause side effects. Polypharmacology remains one of the major challenges in drug development, and it opens novel avenues to rationally design the next generation of more effective, but less toxic, therapeutic agents. This review outlines the latest progress and challenges in polypharmacology studies. |
---|---|
ISSN: | 1751-2433 1751-2441 |
DOI: | 10.1586/ecp.12.74 |